OTLK

Outlook Therapeutics Inc.

Price

$0.63

return (12m)

-42.07%

p/e

-1.37

p/bv

-8.03

DIVIDEND YIELD

0.00%

OTLK price

Outlook Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OTLK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-38.40%

3 months

-13.51%

1 year

-42.07%

2 years

-91.61%

5 years

-98.80%

10 years

-99.92%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals OTLK

Valuation

P/E

-1.37

Sector -4.26

Industry -4.26

P/BV

-8.03

Sector 2.11

Industry 2.11

P/Revenue (PSR)

-77.97

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

3.19

Sector 1.25

Industry 1.25

P/Net Current Assets

-6.22

Sector -5.47

Industry -5.47

P/Working Capital

-15.14

Sector -1.10

Industry -1.10

EPS

-0.45

Sector -1.94

Industry -1.94

BVPS

-0.08

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

100.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

100.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

588.26%

Sector -61.50%

Industry -61.50%

ROA

-233.46%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.81

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

-0.40

Sector 0.43

Industry 0.43

Liabilities/Assets

1.40

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

2.83%

Sector -

Industry -

Fundamentals OTLK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OTLK Outlook Therapeutics Inc.	$0.63	-73.41%	0.00%	-1.37	-8.03	588.26%	100.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OTLK Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Outlook Therapeutics

Outlook Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

16 years

Founded: 2010

2016

Time since IPO - 10 years

8

Employees

Outlook Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $83.43 million, with shareholders equity totaling $-10.39 million.

The company employs approximately 8 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Outlook Therapeutics Inc. reported $-1.07 million in revenue, generating net income of $-61.12 million.

Key financial metrics include a P/E ratio of -1.37, a price-to-book (P/B) ratio of -8.03, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OTLK.

Market cap

$83.43 million

Net worth

$-10.39 million

$-10,390,000.00

Assets

$26.18 million

$26,180,000.00

Total Shares Outstanding

137.00 million

137,000,000

Average Daily Trading Volume

$18.72 million

$18,715,293.38

Sector

Health Care

Industry

Biotechnology

OTLK

OTLK revenue and profits

Financial Results OTLK

DRAG THE FRAME TO SEE MORE DATA

OTLK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Outlook Therapeutics (OTLK) today?

A cotação de Outlook Therapeutics (OTLK) hoje está em US$ 0.63, com uma variação de -42.07% em relação ao último ano. A cotação de Outlook Therapeutics (OTLK) iniciou o ano negociando na casa dos US$ 1.58 e hoje está em US$ 0.63. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Outlook Therapeutics (OTLK) e dados de ações do Ibovespa e mercados internacionais.

Quando Outlook Therapeutics (OTLK) paga dividendos?

Outlook Therapeutics (OTLK) não distribuiu dividendos no último ano.

Is Outlook Therapeutics (OTLK) a good investment?

Atualmente, Outlook Therapeutics (OTLK) está cotada a US$ 0.63, com um P/L de -1.37, representando um desvio de -188% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -42.07 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -42.07%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Outlook Therapeutics (OTLK) stock?

Investir em ações de Outlook Therapeutics (OTLK) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Outlook Therapeutics (OTLK) yield today?

A rentabilidade de Outlook Therapeutics (OTLK) foi de -38.40% no último mês, -42.07% no último ano e -98.80% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Outlook Therapeutics (OTLK) hoje, o investimento total seria de US$ 63.14, com base na cotação atual de US$ 0.63.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 36.58
Em 5 anos: US$ 0.76
Em 10 anos: US$ 0.05

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

OTLK

Outlook Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment OTLK

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING OTLK WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Outlook Therapeutics

Outlook Therapeutics Inc.

United States

16 years

2016

8

PROFIT X PRICE OTLK

Financial Results OTLK

OTLK cash flow

Asset, Revenue and Profit Growth - OTLK

OTLK balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions